Guyon Espiner investigates PHARMAC: The NZ Buyer’s Club

23 May 2019 - Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders ...

Read more →

Two words to help Ned Sharpless revolutionise clinical trials: data standards

13 May 2019 - In the classic 1967 film “The Graduate,” young Benjamin Braddock was given one word of advice ...

Read more →

Grandstanding, not real change: why drug prices in TV ads will be confusing and irrelevant

13 May 2019 - In a fit of hubris, President Trump believes he is making drug makers “come clean” by ...

Read more →

The UK’s new medicines pricing deal – opportunities and risks for pharma

10 May 2019 - January 2019 saw the introduction of the new Voluntary Scheme for Branded Medicines Pricing and Access  ...

Read more →

MPs call for 'life-changing' Kuvan to be made affordable

11 May 2019 - A number of MPs are calling on a drug company to make a "life-changing" treatment affordable ...

Read more →

Lilly's Cyramza (ramucirumab) becomes first FDA approved biomarker-driven therapy in patients with hepatocellular carcinoma

13 May 2019 - This new indication - the fifth FDA approval for Cyramza in an advanced or metastatic cancer - ...

Read more →

Intellipharmaceutics announces FDA approval for generic Pristiq

10 May 2019 - Intellipharmaceutics announced today that it has received approval from the U.S. FDA for the Company's abbreviated new ...

Read more →

Teva and other generic drug makers inflated prices up to 1,000%, State prosecutors say

11 May 2019 - According to a new lawsuit, generic medications including oral antibiotics, blood thinners, cancer drugs, contraceptives and HIV ...

Read more →

'It’s absurd' - allergy sufferers beg PHARMAC to fund EpiPens

13 May 2019 - An ice cream factory in the family sounds like every child’s dream. But for Dylan Wright, just ...

Read more →

U.S. FDA accepts Takeda’s biologics license application for a subcutaneous formulation of vedolizumab (Entyvio) for maintenance therapy in moderately to severely active ulcerative colitis

9 May 2019 - An additional treatment modality would provide more flexibility in how patients receive vedolizumab, a biologic with a ...

Read more →

FDA approves prior approval supplement for Bivigam

10 May 2019 - ADMA Biologics announces that the U.S. FDA has approved the Company’s prior approval supplement for Bivigam (immune ...

Read more →

Sunovion and PsychoGenics announce that SEP-363856 has received FDA breakthrough therapy designation for the treatment of people with schizophrenia

10 May 2019 - SEP-363856 offers an innovative approach to the treatment of schizophrenia including the potential to be the first ...

Read more →

Pharmacy benefit managers are the sole check against drug manufacturers’ pricing power

9 May 2019 - Administration’s proposed rule on rebates increases prescription drug prices, disrupts consumer access. ...

Read more →

Speed up cancer funding, ALP told

11 May 2019 - The head of Australian drug company Specialised Therapeutics, Carlo Montagner, has warned that Bill Shorten’s cancer ...

Read more →

House Democrats pass bill to roll back Trump guidance related to Obamacare

 9 May 2019 - The House passed a bill Thursday afternoon aimed at shoring up protections for those with pre-existing ...

Read more →

Allegations of widespread fraud raise questions about the safety of generic drugs made overseas

10 May 2019 - It is something we've all heard before: generic drugs are the same as brand-name drugs. They ...

Read more →